Diagnosis and treatment of metastatic colorectal cancer: a review
LH Biller, D Schrag - Jama, 2021 - jamanetwork.com
… Colorectal cancer is the third most common cause of cancer … Among people diagnosed
with metastatic colorectal cancer, … The primary treatment for unresectable metastatic CRC is …
with metastatic colorectal cancer, … The primary treatment for unresectable metastatic CRC is …
The association between changes in muscle mass and quality of life in patients with metastatic colorectal cancer
JWG Derksen, SA Kurk, PHM Peeters… - Journal of cachexia …, 2020 - Wiley Online Library
… controlled trial of the Dutch Colorectal Cancer Group that investigated the effect … colorectal
cancer, unresectable metastatic disease, and World Health Organization performance status 0 …
cancer, unresectable metastatic disease, and World Health Organization performance status 0 …
Treatment of metastatic colorectal cancer: ASCO guideline
… , disease-free interval, maximum size of metastases, and WHO performance status, the
estimate of the association of treatment group for OS also showed a significant benefit in favor of …
estimate of the association of treatment group for OS also showed a significant benefit in favor of …
[HTML][HTML] Survival improvement for patients with metastatic colorectal cancer over twenty years
… successive clinical trials in metastatic colorectal cancer (CRC)… the cohort in terms of
performance status or comorbidity, race… higher socioeconomic status, better performance status, …
performance status or comorbidity, race… higher socioeconomic status, better performance status, …
Trifluridine–tipiracil and bevacizumab in refractory metastatic colorectal cancer
… , many of these patients have a good performance status and may be considered for further
… for third-line treatment of refractory metastatic colorectal cancer on the basis of the results of …
… for third-line treatment of refractory metastatic colorectal cancer on the basis of the results of …
Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open …
C Antoniotti, D Rossini, F Pietrantonio… - The Lancet …, 2022 - thelancet.com
… [ECOG] performance status of 0–2 and aged 71–75 years with an ECOG performance status
of 0) … , unresectable, previously untreated metastatic colorectal cancer and adequate organ …
of 0) … , unresectable, previously untreated metastatic colorectal cancer and adequate organ …
[HTML][HTML] Prediction of mortality in metastatic colorectal cancer in a real-life population: a multicenter explorative analysis
H Rumpold, D Niedersüß-Beke, C Heiler, D Falch… - BMC cancer, 2020 - Springer
Background Metastatic colorectal cancer (mCRC) remains a lethal disease. Survival, however,
is increasing due to a growing number of treatment options. Yet due to the number of …
is increasing due to a growing number of treatment options. Yet due to the number of …
[HTML][HTML] Management of BRAF-mutant metastatic colorectal cancer: a review of treatment options and evidence-based guidelines
… mCRC are chemotherapy with bevacizumab as well as 5-fluorouracil, leucovorin, oxaliplatin,
and irinotecan (FOLFOXIRI) plus bevacizumab in patients with a good performance status. …
and irinotecan (FOLFOXIRI) plus bevacizumab in patients with a good performance status. …
[HTML][HTML] Performance status in cancer: not broken, but time for an upgrade?
JM Scott, G Stene, E Edvardsen… - Journal of Clinical …, 2020 - ncbi.nlm.nih.gov
… Presurgical CRF stratification values are defined for lung 47 and colorectal cancer, 58
with less than 15 mL O 2 ⋅kg −1 ⋅min −1 associated with an elevated risk of complications, …
with less than 15 mL O 2 ⋅kg −1 ⋅min −1 associated with an elevated risk of complications, …
… patient data meta-analysis of FOLFOXIRI plus bevacizumab versus doublets plus bevacizumab as initial therapy of unresectable metastatic colorectal cancer
C Cremolini, C Antoniotti, A Stein, J Bendell… - Journal of Clinical …, 2020 - ascopubs.org
… of patients with ECOG performance status 2 was allowed in … meta-analysis had an ECOG
performance status of 0 or 1, … years of age, an ECOG performance status of 0 was required. The …
performance status of 0 or 1, … years of age, an ECOG performance status of 0 was required. The …
相关搜索
- patients with metastatic colorectal cancer
- metastatic colorectal cancer first line treatment
- treatment of metastatic colorectal cancer
- refractory metastatic colorectal cancer
- unresectable metastatic colorectal cancer
- metastatic colorectal cancer systematic review
- metastatic colorectal cancer precision medicine
- metastatic colorectal cancer trifluridine tipiracil
- braf mutant metastatic colorectal cancer
- metastatic colorectal cancer controlled trial
- targeted therapy in metastatic colorectal cancer
- targeted agents in metastatic colorectal cancer
- mortality in metastatic colorectal cancer
- braf v600e metastatic colorectal cancer
- candidate targets metastatic colorectal cancer treatment
- mutant metastatic colorectal cancer beacon study